PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using

First Page		Document Content
Date: 2016-07-12 12:51:48 Medicine Clinical medicine Tyrosine kinase receptors Quinazolines Epidermal growth factor receptor Oncogenes Targeted therapy Biomarker Treatment of cancer Positron emission tomography Imaging biomarker Erlotinib		PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using Add to Reading List Source URL: www.oncodesign.com Download Document from Source Website File Size: 439,16 KB Share Document on Facebook

	Kathrin Warner, M.Sc. Project: Perturbation of mature T-cell homeostasis by the TCL1 family of lymphoid oncogenes Education: DocID: 1rYbV - View Document
	Abstract ErbB2 overexpression gives rise to a highly invasive, aggressive phenotype associated with an enlarged lysosomal compartment and increased activity of the lysosomal proteases, cysteine cathepsins. We have recent DocID: 1rdcC - View Document
	FULL RESEARCH PUBLICATIONS LIST: 2016 Qiu Z, Wilson RS, Liu Y, R Dun A, Saleeb RS, Liu D, Rickman C, Frame M, Duncan RR, Lu WTranslation Microscropy (TRAM) for super-resolution imaging. Scientific Reports 6 Patel DocID: 1r5xr - View Document
	Microsoft Word - The ACM SRC Manual.doc DocID: 1qyUL - View Document
	PRESS RELEASE Oncodesign announces the launch of its first clinical study on a radiotracer in patients with non-small cell lung cancer  First clinical study evaluating a mutated EGFR-receptor marker in patients using DocID: 1qlMF - View Document